A Patient Checklist for Muse Cell Clinic Questions at US-Based Physician-Led Clinics
Aventura, United States - October 24, 2026 / Springs Rejuvenation /
Springs Rejuvenation has released a physician-developed patient checklist designed to help individuals evaluate any clinic offering Muse cell therapy, giving prospective patients a structured framework of questions to ask before pursuing a protocol -- available now across the company's five US-based locations in New York City, Los Angeles, Austin, Miami, and Atlanta.
Why a Checklist, and Why Now
Interest in Muse cell therapy United States clinics has grown alongside broader patient curiosity about regenerative procedures involving stem cells and exosomes. Yet not all clinics approach candidacy screening, informed consent, or follow-up with the same rigor. Springs Rejuvenation developed the checklist specifically to help patients distinguish between facilities that operate under physician supervision and those that do not -- and to clarify what questions matter most before any procedure begins.
The checklist addresses several core areas: how a clinic determines candidacy, what imaging or laboratory work is reviewed before a protocol is recommended, what the peer-reviewed literature actually shows, whether the procedure is characterized accurately as investigational, and how follow-up care is structured after the session.
What Patients Should Ask Any Muse Cell Doctor
Candidacy screening is the first category on the checklist. Patients are encouraged to ask who conducts the evaluation -- a licensed physician or a patient coordinator -- and whether any underlying conditions are assessed before a protocol involving stem cells and exosomes is proposed. At Springs Rejuvenation, physician-supervised intake is standard across all five clinics, with board-certified medical oversight at each location.
Imaging and laboratory review represents the second category. The checklist prompts patients to ask whether blood panels, imaging, or prior medical records are reviewed as part of candidacy determination, and whether results are interpreted by a physician rather than reviewed after the fact.
The third category covers the peer-reviewed literature. A 2018 study published in Stem Cells Translational Medicine by Dezawa and colleagues observed that Muse cells -- a subset of pluripotent-like cells found in adult connective tissue -- may help support tissue repair responses in preclinical models, though the authors noted that human application remains under active investigation. Patients are encouraged to ask any muse cell doctor which specific published findings, if any, inform the protocols being offered, and whether those findings involved human subjects or animal models.
Investigational status is the fourth area. The checklist is direct: Muse cell-related procedures are not FDA-approved therapies, and patients should receive a clear verbal and written explanation of that status before any muse cell clinic questions are considered resolved.
The fifth category addresses follow-up care. Patients are advised to ask how outcomes are monitored, who conducts follow-up appointments, and what the process is if a patient has concerns after a session. US-based physician supervision matters here in ways that stem cell therapy without traveling overseas cannot always replicate -- when a patient is local to a clinic, follow-up visits are logistically feasible, and the supervising physician has direct access to the patient's ongoing records.
Springs Rejuvenation and Physician-Led Oversight
Dr. Charles Pereyra, MD, a board-certified emergency medicine physician who completed his residency at NewYork-Presbyterian Brooklyn Methodist, serves as a physician lead within the Springs Rejuvenation network. Dr. Pereyra holds membership in the International Society of Hair Restoration Surgery (ISHRS) and has authored three papers indexed on PubMed (NPI: 1932553963).
"In my experience, patients who come in having done their research -- who know what questions to ask -- tend to approach the process with clearer expectations," said Dr. Charles Pereyra, MD, of Springs Rejuvenation. "The goal of this checklist is to make sure every patient understands the investigational nature of these procedures and what physician oversight actually looks like before they commit to anything."
The checklist is available to patients exploring muse cell therapy United States options through any of the five Springs Rejuvenation clinics. The company's Stem 3 Protocol incorporates stem cells and exosomes under direct physician supervision, with procedural steps including minimally invasive delivery methods and structured post-session monitoring -- elements patients are now explicitly guided to ask about at any clinic they consider.
The release of this checklist reflects a broader effort to support informed decision-making for patients who want access to stem cell therapy without traveling overseas, while ensuring they understand both the clinical landscape and the limits of current evidence.
Our Stem Cell exosome formula is produced in an FDA approved lab, but is not an FDA approved therapy. It is currently in the experimental stages -- all information provided is based on our experience with patients. Results may vary. Consult with a qualified medical professional.
About Springs Rejuvenation
Springs Rejuvenation operates physician-supervised regenerative medicine clinics across five US locations: New York City, Los Angeles, Austin, Miami, and Atlanta. The company offers protocols involving stem cells and exosomes, including the Stem 3 Protocol, under the oversight of licensed medical professionals. All procedures are characterized as investigational, and candidacy is evaluated on an individual basis by physicians at each location.
Learn more at Springs Rejuvenation
Contact Information:
Springs Rejuvenation
245 5th Ave 3rd Floor Suite 307
Aventura, Florida 10016
United States
Charles Pereyra
(305) 363-0718
https://home.springsrejuvenation.com
